Koch M, Weitz J, Kienle P, Benner A, Willeke F, Lehnert T, Herfarth C, von Knebel Doeberitz M
Division for Molecular Diagnostics and Therapy, Department of Surgery, University of Heidelberg, INF 110, D-69120 Heidelberg, Germany.
Arch Surg. 2001 Jan;136(1):85-9. doi: 10.1001/archsurg.136.1.85.
Metastatic disease in colorectal cancer results from hematogenic dissemination of tumor cells. This dissemination can be explained by 2 concepts: (1) regional spread of tumor cells via portal venous drainage into the liver as the first site of metastasis and (2) early spread of tumor cells into central and peripheral venous blood as evidence of systemic hematogenic tumor cell dissemination.
Tumor cell detection in different blood compartments could help to understand the predominant pattern of hematogenic tumor cell dissemination in colorectal cancer.
Prospective consecutive series.
University hospital.
Mesenteric, central, and peripheral venous blood samples from 40 patients with colorectal cancer were examined by cytokeratin 20 reverse transcriptase polymerase chain reaction.
Sensitivity and specificity of cytokeratin 20 reverse transcriptase polymerase chain reaction, and frequency of tumor cell detection in different blood compartments.
Tumor cells were found in mesenteric venous blood of 20 of 40 patients, central venous blood of 6 of 40 patients, and peripheral venous blood of 2 of 19 patients. The detection rate in mesenteric venous blood was significantly higher than that in central and peripheral venous blood (P<.001).
The significantly higher detection rate in mesenteric venous blood emphasizes the importance of the filter function of the liver for circulating tumor cells in portal venous blood. Tumor cell detection in central and peripheral venous blood, however, shows that this filtering process is limited and indicates early systemic hematogenic tumor cell dissemination in colorectal cancer.
结直肠癌的转移性疾病是由肿瘤细胞的血行播散引起的。这种播散可以用两个概念来解释:(1)肿瘤细胞通过门静脉引流区域扩散至肝脏,作为转移的第一站;(2)肿瘤细胞早期扩散至中央和外周静脉血,作为系统性血行肿瘤细胞播散的证据。
检测不同血腔中的肿瘤细胞有助于了解结直肠癌血行肿瘤细胞播散的主要模式。
前瞻性连续系列研究。
大学医院。
对40例结直肠癌患者的肠系膜、中央和外周静脉血样本进行细胞角蛋白20逆转录聚合酶链反应检测。
细胞角蛋白20逆转录聚合酶链反应的敏感性和特异性,以及不同血腔中肿瘤细胞的检测频率。
40例患者中,20例在肠系膜静脉血中发现肿瘤细胞,40例中有6例在中央静脉血中发现肿瘤细胞,19例中有2例在外周静脉血中发现肿瘤细胞。肠系膜静脉血中的检测率显著高于中央和外周静脉血(P<0.001)。
肠系膜静脉血中显著较高的检测率强调了肝脏对门静脉血中循环肿瘤细胞的滤过功能的重要性。然而,在中央和外周静脉血中检测到肿瘤细胞表明这种滤过过程是有限的,并提示结直肠癌中早期存在系统性血行肿瘤细胞播散。